Search PODD
INSULET CORP
Nasdaq · CIK 1145197
Last close131.69
Daily change+0.90 (0.69%)
10 Years gain+223.40%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
PODD · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
77.2Momentum
63.5Acceleration
38.1Confidence
85.0Annual Revenue17
Quarterly Revenue71
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality17.2 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.6832 percentage points.
Operating leverageOperating margin improved by 2.6974 percentage points.
Share count reductionDiluted share count declined 6.3526%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
ROIC declining · MEDIUMROIC declined by 292.4402 percentage points.
Key Metrics
Revenue Growth TTM42.86%OK
Revenue CAGR 3Y36.9%OK
Gross Margin70.37%OK
Operating Margin16.81%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC73.21%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-6.35%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $2.71B | $1.94B | $473.80M | $569.30M | $377.70M | 71.63% | 17.5% | 13.95% | 59.48% | 71.89M |
| 2025 FY Dec 31, 2024 | $2.07B | $1.45B | $308.90M | $430.20M | $305.30M | 69.79% | 14.91% | 14.74% | 95.63% | 73.89M |
| 2025 FY Dec 31, 2023 | $1.70B | $1.16B | $220.10M | $145.70M | $70.10M | 68.35% | 12.97% | 4.13% | n/a | 73.63M |
| 2024 FY Dec 31, 2022 | n/a | $805.60M | $37.60M | $119.00M | -$3.90M | n/a | n/a | n/a | n/a | 69.91M |
| 2022 FY Dec 31, 2022 | $1.06B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.92B | sum latest 4 fiscal quarters Revenue | OK | 0001145197-26-000169, 0001145197-25-000069 |
| Revenue Growth TTM | 42.86% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001145197-26-000169, 0001145197-25-000069 |
| Revenue CAGR 3Y | 36.9% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001145197-26-000028 |
| Revenue CAGR 5Y | 24.53% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001145197-26-000028 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001145197-26-000028 |
| Operating Income Growth | 70.17% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001145197-26-000169, 0001145197-25-000069 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 70.37% | Gross Profit / Revenue | OK | 0001145197-26-000169, 0001145197-25-000069 |
| Operating Margin | 16.81% | Operating Income / Revenue | OK | 0001145197-26-000169, 0001145197-25-000069 |
| ROIC | 73.21% | NOPAT / Average Invested Capital | OK | 0001145197-26-000169, 0001145197-25-000069 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001145197-26-000169 |
| Current Ratio | 2.48x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 28.3x | (Cash + Short-term Investments) / Total Debt | OK | 0001145197-26-000169 |
| Revenue per Diluted Share | $42.06 | Revenue / Diluted Shares | OK | 0001145197-26-000169, 0001145197-25-000069 |